Nishant Agrawal

Experts at @UChicagoMed successfully treated and cured stage IV oral cancer patient Pat Sirvinskas with a unique approach that spared her tongue. Hear her story in her own words. @HNCancerDoc @AriRosenbergMD @ajuloorimd @UChicagoOHNS ow.ly/ksE550SPooT

We are proud to announce that @UCCancerCenter has been ranked #1 in Illinois and #12 in the nation in the latest U.S. News & World Report's Best Hospitals. We are committed to providing highest quality care to cancer patients. health.usnews.com/best-hospitals…

U.S. News & World Report's Best Hospitals list ranked University of Chicago Medical Center's Cancer and ENT programs highest in Illinois. Additionally, UCMC is one of only 25 hospitals nationwide to have at least 10 ranked specialties. uchicagomedicine.org/forefront/news…

A truly special night celebrating the graduation of our chief residents Drs. Warren and Patel! They were a special duo who will be sorely missed 🥹 They are both off for fellowship @EmoryENT and we look forward to their future accomplishments #ENT #Residency #IamOto

Excited that our OPTIMA II trial is out in @JAMAOnc! Neoadjuvant nivo/chemo -> response-adaptive treatment for HPV+ oropharyngeal cancer @eevokes @lab_pearson @ajuloorimd @HNCancerDoc @EAB_ENT @SysmexInostics @UCCancerCenter @UChicagoMed @UChicagoHemOnc jamanetwork.com/journals/jamao…

@AriRosenbergMD #OPTIMA2 HNSCC DE-ESCALATION study out today @JAMAOnc: 🧑‍🤝‍🧑Broad inclusion N2 to N3 and/or T3 to T4 HPV+ 🙌Excellent OS 💪Chemo/IO induction has high pathCR rates 👄Super-low g-tube rates for max de-escalated pts (green KM curve line) see: ow.ly/Xmqu50Sb99b

@AriRosenbergMD presents results from HB-200, an arenavirus-based vector therapy specifically targeted for HPV+ oropharyngeal cancers. Neoadjuvant HB-200 could be a potential new therapy as induces T-cell responses and reduces ctHPV-DNA. #ASCO24 @UCCancerCenter @UChicagoMed

@AriRosenbergMD at #asco24 sharing a first look at TARGET-HPV. Exciting HPV targeted chemo-immunotherapy neoadjuvant treatment with adaptive de-escalation. A great multi-D effort from @UCCancerCenter @UChicagoHemOnc @UChicagoOHNS @UChicagoRadonc

Manu Sundaresan, 4th year undergrad student @UChicago presents an excellent poster at #AACR24 showing the association of higher levels of PDCD10 expression with poor prognosis in oral squamous cell carcinoma. @UCCancerCenter @HNCancerDoc @EIzumchenko

Congratulations to Alka Singh on receiving “AACR Scholar in Training Award” for presenting important work on “Comprehensive characterization of mitochondrial mutational landscape in the evolution of adenocarcinoma.” @HNCancerDoc @EIzumchenko @UCCancerCenter @UChicagoOHNS

So excited that Drs. Roxbury, Baroody, Shogan, Portugal, Pinto, @EAB_ENT @HNCancerDoc @GluthMichael @DrDanaSuskind have made the list! Such an incredible honor that reflects their dedication to patient care! 👏🏻🤩🤗 #TopDocs2024 #Chicago #ENT #IamOto @uchicagosurgery

An all star squad! #ChicagoTopDocs

ctDNA is a powerful dynamic biomarker with IO-based treatment; Need for prospective ctDNA adaptive immunotherapy trial designs such as our "SINERGY" trial in recurrent/metastatic #headandneckcancer (NCT05420948) @EIzumchenko @ajuloorimd @HNCancerDoc nature.com/articles/s4159…

Has your head and neck tumor grown back? We are looking for people with a diagnosis of head and neck cancer caused by human papillomavirus 16 (HPV16) to enroll in a clinical research study. Clink the link to learn more: Hookipatrials.com

Attention head and neck cancer fighters, survivors, and caregivers! Register now for the 2023 Head and Neck Cancer Symposium. This event is FREE and it is our first year with the option to attend in person (Indianapolis) or virtually. Details: headandneck.org/symposium/

Please join us on Saturday September 2nd for our virtual #ENT program showcase! RSVP with the link below - Excited to meet future applicants! #TheMatch #OtoMatch #IamOto #Residency canva.com/design/DAFruuZ…

AI devices are almost certain to become electronic babysitters—just as previous generations of parents (understandably!) adopted TV as a tool for lightening caregiving duties. Thank you to @WSJ for letting me weigh in on the peril—and promise—of this. wsj.com/articles/the-a…

Proud to announce we have been ranked 32 nationally among #ENT programs in the @usnews annual report! This is a collective effort reflecting tremendous work and relentless dedication amongst the entire section @UChicagoMed @uchicagosurgery uchicagomedicine.org/forefront/news…

Don't miss (August 21st) our next free webinar - "Caregivers - How to care for yourself and your loved one with head and neck cancer." Registration and all the details can be found here: headandneck.org/survivorship-w… #cancereducation #hnca #headandneckcancer #caregivers

Join us for our 2023 Head & Neck Cancer Symposium. Enjoy informative sessions, survivor stories, & opportunities to connect with others on a similar journey. This event is FREE to attend - either in person or virtually. Register or find out more here: headandneck.org/symposium/